Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.45B |
| 2 |
Visa
V
|
+$1.05B |
| 3 |
Microsoft
MSFT
|
+$1.01B |
| 4 |
Apple
AAPL
|
+$578M |
| 5 |
Norfolk Southern
NSC
|
+$545M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$1.24B |
| 2 |
McDonald's
MCD
|
+$707M |
| 3 |
JPMorgan Chase
JPM
|
+$680M |
| 4 |
Texas Instruments
TXN
|
+$678M |
| 5 |
Edwards Lifesciences
EW
|
+$664M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.8% |
| 2 | Healthcare | 2.66% |
| 3 | Financials | 2.38% |
| 4 | Consumer Discretionary | 2.05% |
| 5 | Industrials | 2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12276
IceCure Medical
ICCM
$10.7M
| $37.9K | ﹤0.01% |
1,239
-512
| -29% | -$15.3K |
|
|
BLRX
12277
BioLineRX
BLRX
$12M
| $37.9K | ﹤0.01% |
10,020
-4,934
| -33% | -$19.8K |
|
12278
Commercial Vehicle Group
CVGI
$132M
| $37.6K | ﹤0.01% |
22,100
+5,947
| +37% | +$10.9K |
|
|
RJET
12279
Republic Airways Holdings
RJET
$1.03B
| $37.4K | ﹤0.01% |
1,916
-3,234
| -63% | -$57.1K |
|
|
IMRN
12280
Immuron
IMRN
$8.72M
| $37.4K | ﹤0.01% |
+19,562
| New | +$35K |
|
12281
PUT
Magnachip Semiconductor
MX
$134M
| $37.2K | ﹤0.01% |
11,900
-1,000
| -8% | -$3.39K |
|
12282
CALL
CPS Technologies
CPSH
$81.9M
| $37.1K | ﹤0.01% |
10,400
-3,200
| -24% | -$9.93K |
|
12283
Jowell Global
JWEL
$4.04M
| $37.1K | ﹤0.01% |
+20,947
| New | +$42.7K |
|
|
FBGL
12284
FBS Global
FBGL
$7.94M
| $37K | ﹤0.01% |
48,077
+32,157
| +202% | +$20.1K |
|
|
NAMI
12285
Jinxin Technology Holding
NAMI
$8.86M
| $36.9K | ﹤0.01% |
+1,477
| New | +$38.9K |
|
12286
CALL
Relmada Therapeutics
RLMD
$574M
| $36.8K | ﹤0.01% |
+18,300
| New | +$17.6K |
|
12287
Energy Focus
EFOI
$19.9M
| $36.6K | ﹤0.01% |
+13,181
| New | +$31.7K |
|
12288
TherapeuticsMD
TXMD
$23.6M
| $36.3K | ﹤0.01% |
+34,273
| New | +$38.4K |
|
|
NTZ
12289
Natuzzi
NTZ
$14.6M
| $36.3K | ﹤0.01% |
+11,270
| New | +$35K |
|
|
SCNI
12290
Scinai Immunotherapeutics
SCNI
$1.29M
| $36.2K | ﹤0.01% |
28,630
+17,031
| +147% | +$29.6K |
|
|
12291
CALL
Magnachip Semiconductor
MX
$134M
| $36K | ﹤0.01% |
11,500
-9,300
| -45% | -$31.5K |
|
12292
CALL
Immunic
IMUX
$191M
| $36K | ﹤0.01% |
4,080
+2,760
| +209% | +$24.3K |
|
12293
CALL
Cumberland Pharmaceuticals
CPIX
$116M
| $35.9K | ﹤0.01% |
+11,500
| New | +$38.2K |
|
|
CTOR
12294
Citius Oncology
CTOR
$61.4M
| $35.9K | ﹤0.01% |
+17,661
| New | +$38.3K |
|
12295
CALL
T-Rex 2X Inverse NVIDIA Daily Target ETF
NVDQ
$18.9M
| $35.8K | ﹤0.01% |
+1,945
| New | +$42.8K |
|
|
OLPX
12296
CALL
DELISTED
Olaplex Holdings
OLPX
| $35.8K | ﹤0.01% |
27,300
+6,800
| +33% | +$9.75K |
|
12297
Educational Development Corp
EDUC
$11.8M
| $35.7K | ﹤0.01% |
+26,852
| New | +$33.7K |
|
12298
Seer Inc
SEER
$122M
| $35.6K | ﹤0.01% |
16,424
-234,813
| -93% | -$500K |
|
|
AMTD
12299
AMTD IDEA Group
AMTD
$74.3M
| $35.6K | ﹤0.01% |
31,607
-10,311
| -25% | -$11.1K |
|
12300
Moolec Science
MLEC
$5.22M
| $35.5K | ﹤0.01% |
+2,415
| New | +$97.4K |
|
Similar funds
Citadel Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, Citadel Advisors held 14,587 positions worth $657B, up 14% from $576B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citadel Advisors's Q3 2025 filing shows 2,292 new, 5,365 increased, 4,887 reduced and 1,963 closed positions. Its largest new stake was Permian Resources: 18,381,735 shares worth $235M. The largest sale was Hess, an estimated $1.24B.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3.3% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q3 2025 buy was Permian Resources: 18,381,735 shares worth $235M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q3 2025, an estimated $1.45B increase.
- Citadel Advisors's biggest Q3 2025 reduction was McDonald's, cutting an estimated $707M.
- Citadel Advisors fully exited Hess in Q3 2025, selling an estimated $1.24B.
- Citadel Advisors's ten largest holdings make up 25% of its $657B portfolio in Q3 2025.
- Citadel Advisors opened 2,292 new positions and closed 1,963 in Q3 2025.
- Citadel Advisors's portfolio value rose 14% quarter-over-quarter to $657B.
Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.